<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001741" GROUP_ID="AIRWAYS" ID="462999091509020489" MERGED_FROM="" MODIFIED="2014-06-05 17:23:00 +0100" MODIFIED_BY="Emma Welsh" NOTES="&lt;p&gt;Exported from Review Manager 4.2.7&lt;br&gt;Exported from Review Manager 4.2.1&lt;br&gt;Short title (no longer in use): Speleotherapy for the treatment of asthma&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2014-06-05 17:22:08 +0100" NOTES_MODIFIED_BY="Emma Welsh" REVIEW_NO="SPEL-AST " REVMAN_SUB_VERSION="5.2.7 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="8.0">
<COVER_SHEET MODIFIED="2014-06-05 17:22:05 +0100" MODIFIED_BY="Emma Welsh">
<TITLE>Speleotherapy for asthma</TITLE>
<CONTACT>
<PERSON ID="7172" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Sylvia</FIRST_NAME>
<MIDDLE_INITIALS>P</MIDDLE_INITIALS>
<LAST_NAME>Beamon</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>sylvia@salisburyvillas.freeserve.co.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION/>
<ADDRESS_1>9 Newbolt</ADDRESS_1>
<ADDRESS_2/>
<CITY>Royston</CITY>
<ZIP>SG8 5PU</ZIP>
<REGION>Hertfordshire</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2014-06-05 17:21:43 +0100" MODIFIED_BY="Emma Welsh">
<PERSON ID="7172" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Sylvia</FIRST_NAME>
<MIDDLE_INITIALS>P</MIDDLE_INITIALS>
<LAST_NAME>Beamon</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>sylvia@salisburyvillas.freeserve.co.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION/>
<ADDRESS_1>9 Newbolt</ADDRESS_1>
<ADDRESS_2/>
<CITY>Royston</CITY>
<ZIP>SG8 5PU</ZIP>
<REGION>Hertfordshire</REGION>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="8565" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Albrecht</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Falkenbach</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1/>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION/>
<ADDRESS_1>Bad Gasteiner Heilstollen</ADDRESS_1>
<ADDRESS_2/>
<CITY>Bockstein</CITY>
<ZIP>A-5645</ZIP>
<REGION/>
<COUNTRY CODE="AT">Austria</COUNTRY>
<PHONE_1>43 6434 3753</PHONE_1>
<PHONE_2/>
<FAX_1>43 6434 3766</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="19401" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Grigory</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Fainburg</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1/>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT/>
<ORGANISATION>Perm State University</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Perm</CITY>
<ZIP/>
<REGION/>
<COUNTRY CODE="RU">Russian Federation</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="5894" ROLE="AUTHOR">
<PREFIX>A/Prof</PREFIX>
<FIRST_NAME>Klaus</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Linde</LAST_NAME>
<SUFFIX/>
<POSITION>Research Co-ordinator</POSITION>
<EMAIL_1>klaus.linde@tum.de</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Institute of General Practice</DEPARTMENT>
<ORGANISATION>Klinikum Rechts der Isar</ORGANISATION>
<ADDRESS_1>Orleansstrasse 47</ADDRESS_1>
<ADDRESS_2/>
<CITY>München</CITY>
<ZIP>81667</ZIP>
<REGION/>
<COUNTRY CODE="DE">Germany</COUNTRY>
<PHONE_1>+49 89 614 658 912</PHONE_1>
<PHONE_2/>
<FAX_1>+49 89 614 658 915</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-09-01 11:17:37 +0100" MODIFIED_BY="Toby Lasserson" NOTES="&lt;p&gt;New studies sought but none found: 4/3/06&lt;/p&gt;" NOTES_MODIFIED="2008-09-01 11:17:37 +0100" NOTES_MODIFIED_BY="Toby Lasserson">
<UP_TO_DATE>
<DATE DAY="3" MONTH="4" YEAR="2006"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="3" MONTH="4" YEAR="2006"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="" MONTH="" YEAR=""/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="1999"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2001"/>
</DATES>
<WHATS_NEW MODIFIED="2014-06-05 17:22:05 +0100" MODIFIED_BY="Emma J Welsh">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2014-06-05 17:22:05 +0100" MODIFIED_BY="Emma J Welsh">
<DATE DAY="5" MONTH="6" YEAR="2014"/>
<DESCRIPTION>
<P>PLS title updated</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2014-06-05 17:21:55 +0100" MODIFIED_BY="Emma J Welsh">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2014-06-05 17:21:55 +0100" MODIFIED_BY="Emma J Welsh">
<DATE DAY="29" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="9" MONTH="1" YEAR="2001"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>NHS Research and Development</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>NIAMS Grant No 5 U24-AR-43346-02 (supporting KL)</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Karl und Veronica Carstens-Stiftung (supporting KL)</NAME>
<COUNTRY CODE="DE">Germany</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Askim Insurance Consultants, Histon, Cambridge (supporting SB)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-06-05 17:22:08 +0100" MODIFIED_BY="Toby J Lasserson">
<SUMMARY MODIFIED="2014-06-05 17:22:08 +0100" MODIFIED_BY="Toby J Lasserson">
<TITLE MODIFIED="2014-06-05 17:22:08 +0100" MODIFIED_BY="Toby J Lasserson">Speleotherapy (exposure to salt air, usually underground) for asthma</TITLE>
<SUMMARY_BODY>
<P>Speleotherapy (staying in underground environments) is believed to be of some benefit to people with asthma. People spend short periods in specifically designated caves or mines, sometimes doing particular physical or breathing exercises. There are some wards for longer stays. Benefits are believed to come from air quality, underground climate, air pressure or radiation. These features differ among caves and mines (for example, there are high levels of radiation in some mines, and different types of humidity). No evidence from randomised controlled trials was found and more research is needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-06-04 10:48:02 +0100" MODIFIED_BY="Toby J Lasserson">
<ABS_BACKGROUND>
<P>Speleotherapy, the use of subterranean environments, is a therapeutic measure in the treatment of chronic obstructive airways diseases. It is virtually unknown in the UK or the US, but has considerable widespread use in some Central and Eastern European countries. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To review evidence for the efficacy of speleotherapy in the treatment of asthma.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-06-04 10:45:43 +0100" MODIFIED_BY="Toby J Lasserson">
<P>We searched electronic databases (MEDLINE, EMBASE, Cochrane Airways Specialised Register), contacted speleotherapy centres and experts in the field, handsearched proceedings, and checked bibliographies of articles obtained to identify possible relevant publications. The most recent search was in April 2006. </P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>We included controlled clinical trials (i.e., both randomized and those not reporting the method of allocation) that compared clinical effects of speleotherapy with another intervention or no intervention in patients with chronic asthma.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>Information concerning patients, interventions, results, and methodology were extracted in standardized manner by two independent reviewers and summarized descriptively.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-06-04 10:48:02 +0100" MODIFIED_BY="Toby J Lasserson">
<P>Three trials including a total of 124 asthmatic children met the inclusion criteria, but only one trial had reasonable methodological quality. Two trials reported that speleotherapy had a beneficial short-term effect on lung function. Other outcomes could not be assessed in a reliable manner. </P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-06-04 10:44:20 +0100" MODIFIED_BY="Toby J Lasserson">
<P>Due to the paucity of trials, the available evidence does not permit a reliable conclusion as to whether speleo-therapeutic interventions are effective for the treatment of chronic asthma. Randomized controlled trials with long-term follow-up are necessary</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-06-04 10:44:45 +0100" MODIFIED_BY="Toby J Lasserson">
<BACKGROUND>
<P>Speleotherapy, the use of subterranean environments, is a therapeutic measure in the treatment of chronic obstructive airways diseases. It is virtually unknown in the UK or the US, but has considerable widespread use in some Central and Eastern European countries. </P>
<P>The main curative factors of speleotherapy in caves and mines are thought to be air quality, underground climate and radiation. Two main kinds of air quality can be distinguished - firstly in salt and potash mines and caves, and secondly in karst caves and ore mines. Three forms of climate can be recognised (by temperature) - cold, moderate, warm and three forms of climate (by relative humidity) - low, normal, high and three forms of climate (by pressure) - low, normal, high. There are four forms of radiation - high level due to radon, moderate level - to potassium -40, normal level - to normal karst rock, and low level - to common salt rock (halite) . </P>
<P>In practice there are: (1) cold and moderate karst caves with high humidity, normal pressure and normal radiation level (e.g., Slovak caves); (2) warm karst or granite bedrock caves with high humidity, normal pressure and high radiation level due to radon (e.g. Gasteiner Heilstollen, Badgastein-Bockstein, Austria); (3) potash mines with moderate temperature, normal humidity, high pressure and moderate radiation level (e.g. Berezniki, Russia; Soligorsk, Byelorussia); (4) warm salt mines with low humidity, high pressure and low radiation level (e.g., Solotivo, Ukraine; Tirgu Ocna, Romania; Wieliczka, Poland); (5) salt mines and caves with moderate temperature, low humidity, low pressure and low radiation level (e.g. Chon-Tus, Kirgizia) and others. </P>
<P>In cold caves (temperature 6 - 10 degrees C., relative humidity 80 - 100%) the patients stay daily for about one hour during a three or four week sojourn at the health resort. In most caves, patients are advised to rest during this period. In some caves physical exercises or breathing exercises, including salt aerosols, are recommended. </P>
<P>The caves and mines with a moderate temperature (13 - 20 degrees C., relative humidity 45 - 70%) are used for longer treatment periods (e.g. about 8 to 10 hours 3 to 4 times per week). In Eastern European countries even some kinds of ward have been built in these caves, or mines, to allow the patients to stay in this climate for a longer period of time. </P>
<P>Warm caves (and former mines) (30 - 41 degrees C., relative humidity 70 - 100%) are used for treatment in Italy, France and Austria. In most of these warm caves there is an elevated concentration of radon, which is considered an important component in this form a climatic therapy. Patients stay in these caves for about one hour. Sojourn of three or four weeks at the health resort with entries every day or every other day are recommended. </P>
<P>Several components of the subterranean environment, air quality and climate in the caves and mines have been thought to be relevant in the treatment of asthma. These include:</P>
<P>- absence of normal biotic conditions (e.g. light) <BR/>- temperature difference underground and on the Earth surface <BR/>- natural (but higher than normal) radiation level <BR/>- low mobility of air (&lt;0.1 m/s) and big volume of underground atmosphere and large surface of its interaction with the surrounding area - presence of mineral water drops or hygroscopic minerals' aerosol <BR/>- presence of moderate or high relative humidity for the constant process of condensation and as a result contributing to the pureness of the air, scavenging dust, pollen and gases <BR/>- high rate of air ionisation (by radon or potassium-40) <BR/>- low levels of dust (0.05 mg/m3), pollen ( &lt;30/m3) and gas pollutant concentration (low level of irritation) <BR/>- low levels of bacteria and other bioaerosols contamination <BR/>- constancy of the climate <BR/>- presence of finest aerosols of vital elements (Na, K, Mg, Ca and so on) <BR/>In cold caves, the high relative humidity contributes to the purity of the air.</P>
</BACKGROUND>
<OBJECTIVES>
<P>The objective of the review was to investigate the evidence for the effectiveness of speleotherapy interventions in the treatment of asthma.</P>
<P>The review was planned to address the following questions:<BR/>- Compared to control interventions, does speleotherapy have a positive effect on physiological outcomes, such as peak expiratory flow rates (PEFR), forced expiratory volume (FEV1) or vital capacity in asthmatic patients?<BR/>- Compared to control interventions, does speleotherapy, have a positive influence on quality of life, subjective symptoms, medication use, immunological state, morbidity, and mortality in asthmatic patients?</P>
</OBJECTIVES>
<METHODS>
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>Controlled clinical trials (randomized trials and trials in which the method of allocation to groups was not described).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Patients with chronic stable asthma.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Studies had to include at least one treatment group in which speleotherapy was applied.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>Studies had to include objective or subjective parameters related to asthma, such as lung function, subjective symptoms, quality of life, medication use.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS>
<P>Eligible trials were identified by the following means: </P>
<P>1) The Cochrane Airways Group Specialised Register of trials was searched (the most recent search was run in April 2006 and will be updated annually). The Register is derived from systematic searches of bibliographic databases including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and CINAHL, and handsearching of respiratory journals and meeting abstracts. All records in the Register coded as 'asthma' were searched using the following terms: </P>
<P>Spelaeo* or speleo* or spelio* or cave* or microclimat* or salina* or "salt min*" or "potash min*" or subterraneotherap* or "vital air room" or halochamber* or biotron* or ionotron* or "climat* chamber*" or karst* or radon* or SaltPipe or Sopipa or BreathMaster</P>
<P>2) All citations identified (using the search term speleo*) in EMBASE (from 1991 onwards) and MEDLINE (from 1966 onwards) were screened by KL.</P>
<P>3) Institutions and subjects in Eastern Europe, Austria and Germany known to have expertise in speleotherapy were contacted for further information by SB, AF and GF.</P>
<P>4) Speleological and caving journals as well as proceedings and abstracts from symposia on speleotherapy were handsearched. (This strategy identified the largest number of possible relevant references)</P>
<P>5) References in the identified trials were checked for other possible relevant studies.</P>
</SEARCH_METHODS>
<DATA_COLLECTION>
<P>Literature screening and selection of eligible trials:<BR/>As speleotherapy research has rarely been published in MEDLINE- or EMBASE-listed journals the literature search had to rely primarily on contacting individuals or institutions and hand searching proceedings and abstract collections. As a first step one of the reviewers selected, from the pool of obtained material relating to the speleo-therapeutic treatment of asthma patients, those studies that were prospective, including uncontrolled case series and experiments. The studies had to include asthma patients (solely or as a separately reported subgroup) and report any clinical outcomes measures beyond "success rates". In a second step two reviewers selected from reports passing the first step those meeting the inclusion criteria. Disagreements were resolved by discussion.</P>
<P>Extraction of descriptive characteristics and study results were done by two reviewers using a standard form. </P>
<P>Regarding quality the following indicators were assessed by two reviewers independently:<BR/>- Was allocation to the compared groups described to be randomized?<BR/>- Was the concealment of randomization adequate?<BR/>- Was an attempt made to blind evaluators?<BR/>- Was there a detailed description of numbers and reasons for drop-outs and withdrawals in each group?<BR/>- Might results be biased due to drop-outs and withdrawals?</P>
<P>The primary studies were summarized descriptively because only a small number of trials were identified, the interventions were heterogeneous, and there was insufficient reporting of outcomes. The table of included studies provides a structured summary of the included studies. The following abbreviations were used in the table:<BR/>- Methods: <BR/> A = allocation to groups, <BR/> C = concealment of allocation, <BR/> B = blinding, <BR/> D = report of drop-out and withdrawals, <BR/> S = selection bias after allocation, <BR/> O = other information<BR/>- Patients: <BR/> N = number, <BR/> C = condition, <BR/> D = demographic information, <BR/> R = recruitment, <BR/> S = study setting<BR/>- Interventions: <BR/> S = speleotherapy group, <BR/> C = control group<BR/>- Outcomes: <BR/> L = lung functions, <BR/> S = subjective symptoms, <BR/> M = medication<BR/>- Notes: <BR/> R = conclusion of the authors of the primary study, <BR/> C = comments</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS>
<STUDY_DESCRIPTION>
<P>Only one study fully met the inclusion criteria (<LINK REF="STD-Novotny-1994" TYPE="STUDY">Novotny 1994</LINK>). Two further studies (<LINK REF="STD-Agostini-1989" TYPE="STUDY">Agostini 1989</LINK>, <LINK REF="STD-Makesowa-1989" TYPE="STUDY">Makesowa 1989</LINK>) did not describe how the patients were allocated to the groups, but randomization seemed unlikely in both. We decided to include these two studies given the scarce evidence available.</P>
<P>One study investigated the effects of speleotherapy in a cave in the Lucca region (Alps of Carrara) in Italy (<LINK REF="STD-Agostini-1989" TYPE="STUDY">Agostini 1989</LINK>), one in a Karst cave in the Czech Republic (<LINK REF="STD-Makesowa-1989" TYPE="STUDY">Makesowa 1989</LINK>), and one in a hot tunnel with a high radon level in Austria (<LINK REF="STD-Novotny-1994" TYPE="STUDY">Novotny 1994</LINK>). All three studies were performed on asthmatic children (total number = 124). No study clearly specified inclusion and exclusion criteria.</P>
<P>An update search in April 2006 did not identify any further studies. </P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY>
<P>The study of <LINK REF="STD-Novotny-1994" TYPE="STUDY">Novotny 1994</LINK> seems to be of reasonable quality although a number of details (exact inclusion criteria, concealment of randomization, completeness of follow-up, co-medication, measurement of subjective symptoms) remain unclear in the available reports. The studies by <LINK REF="STD-Agostini-1989" TYPE="STUDY">Agostini 1989</LINK> and <LINK REF="STD-Makesowa-1989" TYPE="STUDY">Makesowa 1989</LINK> are reported in such a manner that a reliable assessment is impossible. However, strong doubts about the adequacy of the methods seem justified. The uneven number of patients in treatment and control group in the trials by <LINK REF="STD-Agostini-1989" TYPE="STUDY">Agostini 1989</LINK> et al. and the way of reporting the methods makes it unlikely that allocation had been randomized. The comparability of the groups is completely unclear. The same applies to the study by <LINK REF="STD-Makesowa-1989" TYPE="STUDY">Makesowa 1989</LINK> which also gives no information on allocation, treatment and characteristics of the control group.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>In the study of <LINK REF="STD-Novotny-1994" TYPE="STUDY">Novotny 1994</LINK> a slight improvement of the lung function was observed at the end of the 3-week treatment period. There were significant differences between treatment and control group in terms of MEF25% and MEF50% although FEV1 did not differ significantly. Nine weeks after treatment no difference between the groups was observed. The authors concluded that speleotherapy had a moderate, transient therapeutic effect. <LINK REF="STD-Agostini-1989" TYPE="STUDY">Agostini 1989</LINK> reported that the children undergoing speleotherapy had better lung function parameters during and after the treatment phase while during follow-up no clear differences could be detected. The authors reported that the children in the treatment group needed less medication than those in the control group during the observation period. The reporting of <LINK REF="STD-Makesowa-1989" TYPE="STUDY">Makesowa 1989</LINK> regarding lung function allows no interpretation. The need of medication at follow-up seems to have been lower in the treatment group.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>At the moment there is insufficient evidence to assess reliably whether speleotherapy (or some forms of it) is beneficial for asthma patients. Apart from the study of <LINK REF="STD-Novotny-1994" TYPE="STUDY">Novotny 1994</LINK> we were not able to find a study which - at least in the form reported - had acceptable scientific quality. </P>
<P>Speleotherapy is relatively widespread in Eastern Europe and there may be relevant studies which we did not find, although we tried to contact experts in the field and asked them to provide data. The publication of this review may motivate researchers of speleotherapy to contact us and provide further studies. However, based on our contacts it does not seem likely that high-quality randomized trials of speleotherapy exist.</P>
<P>As the characteristics of caves and the treatment schedules vary strongly speleotherapy cannot be considered as one single treatment but rather a class of interventions. For example, the only study in our review which fully met the inclusion criteria (<LINK REF="STD-Novotny-1994" TYPE="STUDY">Novotny 1994</LINK>) was performed in a site which has rather unique characteristics on a geophysical level. Positive or negative results obtained with a specific schedule in a defined cave cannot be extrapolated to speleotherapy in general.</P>
<P>Whether speleo-therapeutic treatment has relevant risks is also unclear. We did not find any systematic investigations on that issue although the large number of treatments in Eastern Europe without reports on serious adverse effects suggests that at least short-term risks are small. The high level of radon in some caves has caused concern among some physicians and patients. For example, in an information leaflet on complementary therapies for patients the German Asthma league takes a sceptical position towards speleotherapy in radon caves.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-06-04 10:44:45 +0100" MODIFIED_BY="Toby J Lasserson">
<IMPLICATIONS_PRACTICE>
<P>At present it is not possible to make any recommendations for practice which are based on evidence from rigorous randomised controlled trials.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-06-04 10:44:45 +0100" MODIFIED_BY="Toby J Lasserson">
<P>Further research on speleotherapy seems justified. Such research should be undertaken by institutions actually practicing speleotherapy and reflect current standards of clinical research on asthma. Randomized trials in subterranean 'speleo- hospitals' are actually being planned. However, funding for these trials is still a problem.</P>
<P>While it seems possible that speleotherapy has short-term beneficial effects the major question is whether any of these last over a longer period and whether the treatment is cost-effective.</P>
<P>It may be difficult to separate specific effects due to temperature, humidity, low levels of allergen and other geophysical properties from non-specific effects such as being under the earth. Such non-specific effects might be of major importance in speleotherapy.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>We would like to thank Steve Milan for his help at all steps of the review</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS/>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-06-04 10:46:59 +0100" MODIFIED_BY="Toby J Lasserson">
<STUDIES MODIFIED="2009-06-04 10:46:59 +0100" MODIFIED_BY="Toby J Lasserson">
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Agostini-1989" NAME="Agostini 1989" YEAR="89">
<REFERENCE NOTES="&lt;p&gt;Agostini G, Baldini G, Dellavalle F, et al. Preliminary results of the first Italian trial of speleotherapy (Cave of the Wind, Lucca, Italy) in atopic asthmatic children. Proceedings of the Symposium on Speleotherapy - Interasma '89. Prague, May 17-20, 1989, 29-33&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Agostini G, Baldini G, Dellavalle F, Gotti A, Lapucci E, Lapucci PL, et al</AU>
<TI>Preliminary results of the first Italian trial of speleotherapy (Cave of the Wind, Lucca, Italy) in atopic asthmatic children</TI>
<SO>Proceedings of the Symposium on Speleotherapy - Interasma '89</SO>
<YR>1989</YR>
<PG>29-33</PG>
<CY>Prague</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Makesowa-1989" NAME="Makesowa 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Makesova D, Ricny D. A long-term study of children with bronchial asthma who underwent speleotherapy treatment. Proceedings of the Symposium on Speleotherapy - Interasma '89. Prague, May 17-20, 1989, 67-70&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Makesova D, Ricny D</AU>
<TI>A long-term study of children with bronchial asthma who underwent speleotherapy treatment</TI>
<SO>Proceedings of the Symposium on Speleotherapy - Interasma '89</SO>
<YR>1989</YR>
<PG>67-70</PG>
<CY>Prague</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Novotny-1994" NAME="Novotny 1994" YEAR="94">
<REFERENCE NOTES="&lt;p&gt;Novotny A, Kr&amp;#228;mer E, Steinbrugger B, et al. Der therapeutische Einfluss von Radon-Inhalation und Hyperthermie im Gasteiner Heilstollen auf das Asthma bronchiale im Kindesalter. Procs. of Tenth International Symposium for Speleotherapy, Vienna 1994;48:198-202.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Novotny A, Krämer E, Steinbrugger B, Fabian J, Eber E, Sandri B, et al</AU>
<TI>Therapeutic effect of radon inhalation and hyperthermy in the curative Gastein galleries on children with bronchial asthma</TI>
<TO>Der therapeutische Einfluss von Radon-Inhalation und Hyperthermie im Gasteiner Heilstollen auf das Asthma bronchiale im Kindesalter</TO>
<SO>Die Höhle</SO>
<YR>1994</YR>
<VL>48</VL>
<NO>Suppl</NO>
<PG>198-202</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Bernatzky-1994" NAME="Bernatzky 1994" YEAR="94">
<REFERENCE NOTES="&lt;p&gt;Der Einfluss einer Heilstollenbehandlung auf die Lungenfunktion. Procs. of Tenth International Symposium for Speleotherapy, Vienna, 1994;48:185-197.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bernatzky G, Leiner G, Adam H</AU>
<TI>The influence of thermal gallery on lung function</TI>
<TO>Der Einfluss einer Heilstollenbehandlung auf die Lungenfunktion</TO>
<SO>Die Höhle</SO>
<YR>1994</YR>
<VL>48</VL>
<NO>Suppl</NO>
<PG>185-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Homolka-1989" NAME="Homolka 1989" YEAR="89">
<REFERENCE PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Homolka P, Drazil V, Slavik P, Vendrackova J</AU>
<TI>Comparison of physical fitness, basic spirometric values and blood gases in children with bronchial asthma before and after speleotherapy treatment</TI>
<SO>Proceedings of the Symposium on Speleotherapy - Interasma '89</SO>
<YR>1989</YR>
<PG>71-5</PG>
<CY>Prague</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khamzamylin-1990" NAME="Khamzamylin 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Khamzamulin RO. Kachkynbaev KA. Abdyldaeva SO. Davletova RA. [The effect of verapamil on external respiratory function in bronchial asthma patients during high-altitude speleotherapy]. [Russian] [Clinical Trial. Journal Article. Randomized Controlled Trial] Voprosy Kurortologii, Fizioterapii i LechebnoiFizicheskoi Kultury. (1):40-3, 1990 Jan-Feb. UI: 2139996&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khamzamylin R, Kachynbaez K, Abdyldaeva S, Davletova R</AU>
<TI>Verapamil hydrochloride effect on external respiration in patients with bronchial asthma on high altitude speleotherapy</TI>
<SO>Voprosy Kurortologii, Fizioterapii i LechebnoiFizicheskoi Kultury</SO>
<YR>1990</YR>
<VL>Jan-Feb</VL>
<NO>1</NO>
<PG>40-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lemko-1994" NAME="Lemko 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Lemko I, Lemko O. Influence of speleotherapy upon the lung function of patients with bronchial asthma. Procs. of Tenth International Symposium for Speleotherapy, Vienna, 1994;48:143-146.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lemko I, Lemko O</AU>
<TI>Influence of speleotherapy upon the lung function of patients with bronchial asthma</TI>
<TO>Einfluss der Speläotherapie auf die Lundenfunktion bei Patienten mit Asthma bronchale</TO>
<SO>Die Höhle</SO>
<YR>1994</YR>
<VL>48</VL>
<NO>Suppl</NO>
<PG>143-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sokolov-1994" NAME="Sokolov 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Comparison of clinical, laboratory and spirometric findings in patients with atopic bronchial asthma and asthmatic bronchitis. Wissenschaftliche Beihefte zur Zeitschrift &amp;quot;Die H&amp;#246;hle&amp;quot;, 1994;48:149-150.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sokolov N, Chonka J, Gorbachov V, Simyonka V</AU>
<TI>Comparison of clinical, laboratory and spirometric findings in patients with atopic bronchial asthma and asthmatic bronchitis</TI>
<SO>Die Höhle</SO>
<YR>1994</YR>
<VL>48</VL>
<NO>Suppl</NO>
<PG>149-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Timov_x00e1_-1989" NAME="Timová 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Timov&amp;#225; S, Dluholuck&amp;#253; S, Sv&amp;#225;c J. Speleotherapy in treatment of children with recurrent obstructive bronchitis. Proceedings of the Symposium on Speleotherapy - Interasma '89. Prague, May 17-20, 1989, 61-62.&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Timová S, Dluholucký S, Svác J</AU>
<TI>Speleotherapy in treatment of children with recurrent obstructive bronchitis</TI>
<SO>Proceedings of the Symposium on Speleotherapy - Interasma '89</SO>
<YR>1989</YR>
<PG>61-2</PG>
<CY>Prague</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-06-04 10:46:59 +0100" MODIFIED_BY="Toby J Lasserson">
<STUDY DATA_SOURCE="UNPUB" ID="STD-Leichsenring-2002" MODIFIED="2009-06-04 10:46:59 +0100" MODIFIED_BY="Toby J Lasserson" NAME="Leichsenring 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-06-04 10:46:59 +0100" MODIFIED_BY="Toby J Lasserson" PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Leichsenring M</AU>
<TI>Controlled, randomised, multi-centre study to determine the effect of Speleotherapy in children between 4 and 10 years</TI>
<TO>Kontrollierte, randomisierte Multizenterstudie zum Nachweis der Wirksamkeit der Spälotherapie bei Kindern zwischen 4 und 10 Jahren mit Asthma bronchiale</TO>
<SO>Unpublished thesis</SO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES>
<ADDITIONAL_REFERENCES>
<REFERENCE ID="REF-Fodor-1973" NAME="Fodor 1973" NOTES="&lt;p&gt;Fodor I. Cave-climatic investigation of the Karstic regions of Aggtelek, and the Mecsek'. Karszt-es Barlangkutatas Kiadja az Mtesz Kereteben Mukodo, Magyar Karszt-es Barlangkutato Tarsulat, Budapest, Hungary. 1973; 137-145.&lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Fodor I</AU>
<TI>Cave-climatic investigation of the Karstic regions of Aggtelek, and the Mecsek</TI>
<SO>Karszt-es Barlangkutatas</SO>
<YR>1973</YR>
<VL>VII</VL>
<PG>137-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fodor-1977" NAME="Fodor 1977" NOTES="&lt;p&gt;Fodor I. Speleoclimatological Research in Hungary: Results and Speleotherapeutic applications. Karszt es Barlang Special Issue, Budapest, Hungary. 1977; 31-34.&lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Fodor I</AU>
<TI>Speleoclimatological Research in Hungary: Results and Speleotherapeutic applications</TI>
<SO>Karszt es Barlang</SO>
<YR>1977</YR>
<VL>Spec</VL>
<PG>31-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hille-1975" NAME="Hille 1975" NOTES="&lt;p&gt;Hille H. Spel&amp;#228;otherapie in der &amp;quot;M&amp;#252;nstertalh&amp;#246;hle&amp;quot; (Schwarzwald, Bundesrepublik Deutschland). Die H&amp;#246;hle 1975;26:81-88.&lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Hille H</AU>
<TI>Speleotherapy in the Münstertal cave</TI>
<TO>Speläotherapie in der "Münstertalhöhle" (Schwarzwald, Bundesrepublik Deutschland)</TO>
<SO>Die Höhle</SO>
<YR>1975</YR>
<VL>26</VL>
<PG>81-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jadad-1996" NAME="Jadad 1996" NOTES="&lt;p&gt;Jadad AR., Moore, R. A., Carrol, D. et al. Assessing the quality of reports of randomized trials: is blinding necessary. Contr. Clin. Trials 1996; 12: 1-12.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Jadad AR, Moore RA, Carrol D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al</AU>
<TI>Assessing the quality of reports of randomized trials: is blinding necessary</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1996</YR>
<VL>12</VL>
<PG>1-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kessler-1975" NAME="Kessler 1975" NOTES="&lt;p&gt;Kessler, H. et al. 'Uber die Heilwirkung der Hohlen' . Procs. UIS International Symposium, Cave Biology and Cave Paleontology held in Oudtshoorn, S. Africa. 1975 Aug 3 - 6; 13-17 [German with English &amp;amp; French summary]&lt;br&gt;&lt;/p&gt;" TYPE="CONFERENCE_PROC">
<AU>Kessler H, et al</AU>
<TO>Uber die Heilwirkung der Hohlen</TO>
<SO>Procs. UIS International Symposium, Cave Biology and Cave Paleontology held in Oudtshoorn, S. Africa Aug 3 - 6</SO>
<YR>1975</YR>
<PG>13-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maximovich-1972" NAME="Maximovich 1972" NOTES="&lt;p&gt;Maximovich, G.A., Khoroshavin, N.G. 'The Types of Natural and Artificial Caves, used for Medical Purposes (Speleotherapeutics). 1972; 129-149 [Russian]&lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Maximovich GA, Khoroshavin NG</AU>
<TI>The types of natural and artificial caves, used for medical purposes</TI>
<SO>Speleotherapeutics</SO>
<YR>1972</YR>
<PG>129-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Roda-1973" NAME="Roda 1973" NOTES="&lt;p&gt;Roda, S. and Rajman, L. 'Die Erforschung und die Bedingungen der Spelaotherapie in der Slowakei' [in Slovensky Kras XI] 1973; 99 - 109. [German with French summary]&lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Roda S, Rajman L</AU>
<TO>Die Erforschung und die Bedingungen der Spelaotherapie in der Slowakei</TO>
<SO>Slovensky Kras</SO>
<YR>1973</YR>
<VL>XI</VL>
<PG>99 -109</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Roda-1980" NAME="Roda 1980" NOTES="&lt;p&gt;Roda, S. and Rajman, L. 'Z Cinnosti Komisie UIS pre Speleoterapui a Speleomedicinu - Aktivita Odbornikov Z CSSR' [On the UIS activity of speleotherapy and speleomedicine - the activity of experts from CSSR] in Slovesky Kras XVIII. 1980; 231-35 [Slovakian]&lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Roda S, Rajman L</AU>
<TI>On the UIS activity of speleotherapy and speleomedicine - the activity of experts from CSSR</TI>
<TO>Z Cinnosti Komisie UIS pre Speleoterapui a Speleomedicinu - Aktivita Odbornikov Z CSSR</TO>
<SO>Slovesky Kras</SO>
<YR>1980</YR>
<VL>XVIII</VL>
<PG>231-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Roda-1982" NAME="Roda 1982" NOTES="&lt;p&gt;Roda, S. and Rajman, L. 'Antropogenne Negativne VPlyvy V Krase a Speleoterapia' [Anthropogenic negative effects on karst and speleotherapy] in Slovensky Kras XX. 1982; 175-78&lt;br&gt;&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Roda S, Rajman L</AU>
<TI>Anthropogenic negative effects on karst and speleotherapy</TI>
<TO>Antropogenne Negativne VPlyvy V Krase a Speleoterapia</TO>
<SO>Slovensky Kras</SO>
<YR>1982</YR>
<VL>XX</VL>
<PG>175-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ronaki-1973" NAME="Ronaki 1973" NOTES="&lt;p&gt;Ronaki, L. 'Radiological Measurements in the Caves of Mecsek Region' in Karszt-es Barlangkutatas Kiadja az Mtesz Kereteben Mukodo, Magyar Karszt-es Barlangkutato Tarsulat, Budapest. 1973; 127-35 [English account of caves used as a cure for pulmonary conditions]&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" TYPE="OTHER">
<AU>Ronaki L</AU>
<TI>Radiological measurements in the caves of Mecsek Region</TI>
<SO>Karszt-es Barlangkutatas</SO>
<YR>1973</YR>
<VL>VII</VL>
<PG>127-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Symposium-1986" NAME="Symposium 1986" TYPE="CONFERENCE_PROC">
<TI>Proceedings of the Symposium on Speleotherapy, Blansko, Czechoslovakia, 20-24 February</TI>
<YR>1986</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Symposium-1992" NAME="Symposium 1992" NOTES="&lt;p&gt;Proceedings of the 10th International Symposium of Speleotherapy, Bad Bleiberg, 1992, publ. Wien, 1994 - Commission de Speleotherapie de l'Union Internationale de Speleologie (UNESCO) &lt;br&gt;&lt;/p&gt;" TYPE="BOOK">
<AU>Commission de Speleotherapie de l'Union Internationale de Speleologie (UNESCO)</AU>
<SO>Proceedings of the 10th International Symposium of Speleotherapy 1992</SO>
<YR>1994</YR>
<PB>Wien Commission de Speleotherapie de l'Union Internationale de Speleologie (UNESCO)</PB>
<CY>Bad Bleiberg</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Trombe-1952" NAME="Trombe 1952" NOTES="&lt;p&gt;Trombe, F. 'Les Climats Souterrains: Thermique et Meteorology Souterraines'. Traite de Speleologie, Payot, Paris. 1952; 92 - 127 [French]&lt;br&gt;&lt;/p&gt;" TYPE="BOOK_SECTION">
<AU>Trombe F</AU>
<TI>The underground climates: thermal and underground meteorology</TI>
<TO>Les Climats Souterrains: Thermique et Meteorology Souterraines</TO>
<SO>Traite de Speleologie</SO>
<YR>1952</YR>
<PG>92-127</PG>
<PB>Payot</PB>
<CY>Paris</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-06-04 10:46:25 +0100" MODIFIED_BY="Toby J Lasserson">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-06-04 10:46:25 +0100" MODIFIED_BY="Toby J Lasserson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Agostini-1989">
<CHAR_METHODS>
<P>A: unclear<BR/>C: unclear<BR/>B: unclear (probably no blinding)<BR/>D: partly described<BR/>S: major bias unlikely<BR/>O: follow-up 12 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N: 26 included, 23 analyzed (16 in the treatment and 7 in the control group)<BR/>C: atopic asthma<BR/>D: children (no further information)<BR/>R: unclear<BR/>S: four Italian clinics and institutes</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>I: 78 to 110 hours in a cave (dolomite limestone and rock, 11°C, 98-100% humidity) during a 3 week period<BR/>C: no speleotherapy<BR/>No information on other therapies</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>L: improvement of lung function during the treatment phase in the speleotherapy groups, follow-up results do not seem to show a clear effect (insufficient data given)<BR/>S: not mentioned<BR/>M: seem to have been lower in the speleotherapy group</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>A: no conclusions presented<BR/>C: insufficient presentation, study hardly assessable</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-06-04 10:46:13 +0100" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Makesowa-1989">
<CHAR_METHODS MODIFIED="2008-09-01 11:19:37 +0100" MODIFIED_BY="Toby J Lasserson">
<P>A: unclear (randomisation unlikely)<BR/>C: unclear (probably inadequate)<BR/>B: probably none<BR/>D: not described<BR/>S: unclear<BR/>O: possibly case-control design, follow-up between 1 and 5 years</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N: included ?/?, analyzed 37/28<BR/>D: asthma (47 also had pollinosis)<BR/>D: age 7 - 13 years, 47 boys, 18 girls<BR/>R: unclear<BR/>S: allergology department of National Health Institutes in Brno (Czech Rep.)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>I: speleotherapy in a local Karst cave (no further details)<BR/>C: no speleotherapy (no further details)<BR/>Both groups seem to have received anti-asthmatic drugs</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>L: no interpretable results presented<BR/>S: no data presented<BR/>M: drug use seems to be lower in speleotherapy group (presented results hardly interpretable)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-06-04 10:46:13 +0100" MODIFIED_BY="Toby J Lasserson">
<P>A: positive<BR/>C: insufficient presentation, therefore study could not be reliably assessed or interpreted</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-06-04 10:46:25 +0100" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Novotny-1994">
<CHAR_METHODS MODIFIED="2009-06-04 10:46:25 +0100" MODIFIED_BY="Toby J Lasserson">
<P>A: children were matched into pairs (based on clinical symptoms, allergy status, lung function) and then randomized<BR/>C: unclear<BR/>D: not mentioned<BR/>S: unclear (but not likely)<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>N: 30 included, 30 analyzed (?)<BR/>C: asthma (mean FEV1 before therapy slightly below 80% of the predicted value)<BR/>D: age 7 to 15 years, 20 boys and 10 girls<BR/>R &amp; S: children were invited to a cost-free 3 week holiday in a health resort in Badgastein, Austria</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>S: 10 times 1 hour stay in the radon-thermal climate (granite, 38-41.5°C, humidity 75-90%)<BR/>C: no speleotherapy<BR/>In addition both group participated to the same activity and free time programme in the resort. No information on medication</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Outcome measurement 3 weeks before admission, at admission, at discharge and 9 weeks after discharge<BR/>L: slight improvement in the speleotherapy group compared to control group (significant differences for MEF50% and MEF25% but not for FEV1), worsening in both groups after discharge (interpreted as a seasonal effect)<BR/>S: no information<BR/>M: no information</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>A: speleotherapy in the investigated cave has a moderate and transient therapeutic effect<BR/>C: study seems to be quite reliable. Reporting not fully satisfactory; only minor additional information could be obtained</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-09-01 11:20:03 +0100" MODIFIED_BY="Toby J Lasserson" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Bernatzky-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>uncontrolled observational study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Homolka-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>uncontrolled observational study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-09-01 11:20:03 +0100" MODIFIED_BY="Toby J Lasserson" STUDY_ID="STD-Khamzamylin-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-09-01 11:20:03 +0100" MODIFIED_BY="Toby J Lasserson">
<P>not randomised </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lemko-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>uncontrolled case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sokolov-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>uncontrolled case series</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Timov_x00e1_-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>controlled study on recurrent obstructive bronchitis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Leichsenring-2002">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2008-09-01 11:19:52 +0100" MODIFIED_BY="Toby J Lasserson">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2008-09-01 11:19:52 +0100" MODIFIED_BY="Toby J Lasserson" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-01 11:19:27 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Agostini-1989">
<DESCRIPTION>
<P>Information not available </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-01 11:19:48 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Makesowa-1989">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2008-09-01 11:19:52 +0100" MODIFIED_BY="Toby J Lasserson" RESULT="UNKNOWN" STUDY_ID="STD-Novotny-1994">
<DESCRIPTION>
<P>Information not available</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES/>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS/>
</COCHRANE_REVIEW>